We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Misys | LSE:MSY | London | Ordinary Share | GB00B45TWN62 | ORD 1 1/7P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.70 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/2/2005 16:10 | Can anyone tell me what the £213 million of intangibles assets are? Should I be worried about gearing of 135%!!!! | praipus | |
04/2/2005 08:55 | rumour is big contract coming soon | carrick | |
28/1/2005 12:21 | Not a share to generate long term profits, however it is a great share to trade when the opportunity arises. | eastbourne1982 | |
28/1/2005 10:57 | Tempus - The Times No thrills, no spills - Misys is a smoother tech ride THE KEY to appreciating Misys, the technology company, is to forget that it is a technology company. Technology companies produce thrills and spills in equal measure. Misys gives investors a much more sedate run for their money...........The long-term prospects for Misys's US healthcare business look similarly robust. The introduction of electronic storage of US medical records is fuelling demand currently. Sesame, the financial adviser arm of Misys, has had a harder time coping with changes to the regulatory picture. But the environment is settling. A much-anticipated sale of this business might happen in the next 18 months. Buy. FULL ARTICLE- 28.01.05 :an article in the FT comments: in the past three years, in common with peers, Misys has been hurt by the financial services sector's reluctance to invest in new IT systems. But if the banks do start buying again, and if Misys starts to suceed in the promising US healthcare market, the outlook is improving - even if Mr Lomax is right to stay cautious. On consensus eps forecasts of about 15p for 2005, Misys is trading at a PE of 14 times, which is modest for the sector and may encourage the brave to step in, the paper says. Deutsche Bank ups target to 206p; Lehman 'overweight' | lyntwyn | |
28/1/2005 10:53 | 27.01.05 :+11.25, (211.5) investors were reassured by the group's in line interim results and unchanged outlook, dealers said. Deutsche Bank said Misys' interim results were in line with the group's pre-close period, and added the outlook "reads well". Therefore, the broker said it expects the share price to benefit from a relief rally as the stock has been a "jam-tomorrow story" for some time. Furthermore, Deutsche said the shares' valuation is not overly expensive. It reiterated its 'hold' recommendation and 205 pence price target. Merrill Lynch said Misys' reported interim EPS was within the group's guidance and ahead of its own estimate, while revenues were slightly ahead of its expectations, due to a better-than-expected performance from Healthcare and a stronger performance from Sesame. The broker maintained its 'neutral' rating on the stock, saying the market outlook for Healthcare remains good, but Sesame's multi-tie offering launch is not anticipated to have an impact on revenues until the next financial year. Citigroup Smith Barney also said Misys' interim results were "broadly in line" with the group's latest trading update. However, it maintained its 'sell' recommendation on the stock and 195 pence price target due to concerns over the continued decline in licence revenues in the Banking and Healthcare divisions, and as the group's conglomerate business model remains an area of concern, in its view. CSFB was also negative as the outlook from Misys is mixed, it said, with some worrying detail. The broker explained a shift in the revenue mix, with banking and healthcare contracts becoming more complex, is likely to put pressure on the margins. It retained its 'underperform' stance on Misys and 190 pence price target. | lyntwyn | |
24/1/2005 10:22 | cover - Going in the same direction as Nasdaq and Techmark (DOWN). I suggest you do a bit more research, i.e. looking at LOG and ARM etc. Not stock specific. | eastbourne1982 | |
24/1/2005 10:10 | hampsterhunter..hell | cover | |
19/1/2005 09:18 | does anyone know when this is going ex div? | cover | |
18/1/2005 15:06 | Quiet here. I ttok the opportunity to pick some of these up at 205p hoping for a run up to the results. | hampsterhunter | |
04/1/2005 12:36 | Does anyone know anything about the floatation of Sesame by Misys? I thought it was supposed to happen any time now. TIA | reflectivetrevor | |
23/12/2004 13:46 | 20.12.04 WestLB upgraded Misys to 'outperform' from 'neutral' and increased its price target to 250 pence from 200. The trading statement is "positive" in WestLB's view. Meanwhile, Merrill Lynch highlighted that Misys is indicating full year adjusted basic EPS to be in the range of 6.6 to 6.9 pence per share, compared to last year's number of 6.8 pence. Merrill believes that consensus estimates were 6.3 pence and its own forecast was 6 pence. Merrill said it will likely make small upward revisions to its below-consensus forecasts but the the broker kept its 'neutral' recommendation. In Bridgewell's view, Misys' trading update suggests a modest uptick in banking performance with licence fee order intake up 4% and total revenues up 2%. Bridgewell added that its professional services performance was particularly strong, due not only to the larger scale of project opportunities coming through, but also to Misys' better organised approach to this area. Meanwhile, Bridgewell highlighted that Healthcare was modestly disappointing with underlying revenues up only 2 pct, below the broker's expectations. Also, Bridgewell said it continues to have reservations about the strength of competition in the medical record area. Bridgewell reiterated its 'core holding' rating on the stock. | lyntwyn | |
20/12/2004 10:36 | Bear-ravaged banks tighten purse strings By Mike Verdin, Times Online The damage the bear market wrought on investment banks has caused a long-term tightening of their purse strings, Misys, the banking and healthcare software company, has said. Misys said that, while like-for-like revenues at its banking division rose by 2 per cent in the June-to-November period, deals had become more difficult to sign off........ .....Like-for-like takings at the division rose 2 per cent during the half. Group revenues, including the impact of disposals, were 7 per cent lower at £471.1 million. "Our trading performance in the first half of this year demonstrates encouraging momentum," said Kevin Lomax, the Misys chairman, said. "All of the lead indicators in our main markets are positive and our expectations for the full year have not changed." Full article can be found here - | lyntwyn | |
19/12/2004 10:39 | I have opened a small short position with a tight stop loss. Somehow I don't think the banks are spending yet, and this share will suffer just like RTR. Also it is now trading close to top of its trading range and it will take some exceptionally good news/bullish outlook in order to drive the share price forward. | mozza0508 | |
17/12/2004 13:22 | T&G today said HOLD/Trading Buy Morgan Stanley said "overweight" on 14th Dec. | mollymolly | |
17/12/2004 10:28 | Announcemnet on Monday. Agree, IF banks start buying again, then lots of upside. | mollymolly | |
16/12/2004 21:41 | There is something happening but I dont know what. Banks will start upgrade and who will benifit. | finess | |
22/10/2004 06:58 | Anyone know what all this share buying back means? They've been buying back shares every day for a while now - is this because they are confident that the share price will rise? | rob_1 | |
05/9/2004 16:43 | 02.09.04 :+2, (181.75) upgraded to 'buy' from 'neutral' at UBS on valuation grounds, with a new price target of 205 pence, dealers said. In a note to clients, the broker said the group's share buyback programme had provided continuing support. Misys has bought back a total of 35m shares since its last AGM and UBS estimated it can buy back a total of 56m shares, leaving scope for further activity. Ahead of the group's AGM on Sept 28, UBS said it expected the management of Misys to make similar comments to those made with full year 2004 results of a 'generally improving' banking software market and 'resilient' US healthcare market. The broker previously had a 215 pence target on the software group. | lyntwyn | |
19/8/2004 21:33 | Anyone watched the heavy trading at the close today? Any thoughts? | great2222 | |
16/8/2004 22:30 | I imagine this will rise early in the morning with the rest of the market as a reaction to the Dow's rise. I will then pick my point at which to go short as this is very obviously going to continue its downtrend in the short to medium term. I am also predicting there could be a profit warning, only a hunch, who knows. | eastbourne1982 | |
07/8/2004 13:00 | Check out OMG (www.omg3d.com / www.vicon.com) With world class products, new markets opening up and cash available for further acquisitions, we expect OMG's turnover to increase dramatically in the next twelve months. Our fair value price targets for OMG are: July 2005 : 52p (market cap. £28 million) + 116% on current level July 2006 : 91p (market cap. £49 million) + 279% on current level Current Price : 24p (market cap. £13 million) Siggraph event starting Monday 9th August will generate significant sales for new MX system | explorer88 | |
29/7/2004 16:39 | Sold most of the purchases at decent profit today, still looks undemanding to me? | spadam | |
28/7/2004 17:14 | Any thoughts on share buy back? On a valuation basis it don't look demanding. | spadam | |
27/7/2004 17:04 | Bully of what? Fair jump today. | spadam | |
27/7/2004 11:22 | You've been warned. Bully | bullishbuyer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions